Logo image of AMC.DE

ALBEMARLE CORP (AMC.DE) Stock Fundamental Analysis

Europe - FRA:AMC - US0126531013 - Common Stock

77.61 EUR
-1.79 (-2.25%)
Last: 10/22/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to AMC. AMC was compared to 66 industry peers in the Chemicals industry. While AMC seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, AMC is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year AMC has reported negative net income.
In the past year AMC had a positive cash flow from operations.
Of the past 5 years AMC 4 years were profitable.
Each year in the past 5 years AMC had a positive operating cash flow.
AMC.DE Yearly Net Income VS EBIT VS OCF VS FCFAMC.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

AMC has a Return On Assets of -6.34%. This is in the lower half of the industry: AMC underperforms 78.79% of its industry peers.
Looking at the Return On Equity, with a value of -10.70%, AMC is doing worse than 74.24% of the companies in the same industry.
Industry RankSector Rank
ROA -6.34%
ROE -10.7%
ROIC N/A
ROA(3y)6.03%
ROA(5y)4.56%
ROE(3y)12.4%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
AMC.DE Yearly ROA, ROE, ROICAMC.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

Looking at the Gross Margin, with a value of 7.76%, AMC is doing worse than 86.36% of the companies in the same industry.
AMC's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for AMC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.02%
GM growth 5Y-49.18%
AMC.DE Yearly Profit, Operating, Gross MarginsAMC.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

4

2. Health

2.1 Basic Checks

AMC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AMC has about the same amount of shares outstanding.
Compared to 5 years ago, AMC has more shares outstanding
Compared to 1 year ago, AMC has an improved debt to assets ratio.
AMC.DE Yearly Shares OutstandingAMC.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
AMC.DE Yearly Total Debt VS Total AssetsAMC.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 1.76, we must say that AMC is in the distress zone and has some risk of bankruptcy.
AMC has a Altman-Z score of 1.76. This is in the lower half of the industry: AMC underperforms 68.18% of its industry peers.
A Debt/Equity ratio of 0.31 indicates that AMC is not too dependend on debt financing.
The Debt to Equity ratio of AMC (0.31) is better than 65.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 1.76
ROIC/WACCN/A
WACC7.63%
AMC.DE Yearly LT Debt VS Equity VS FCFAMC.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

AMC has a Current Ratio of 2.31. This indicates that AMC is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of AMC (2.31) is better than 72.73% of its industry peers.
AMC has a Quick Ratio of 1.47. This is a normal value and indicates that AMC is financially healthy and should not expect problems in meeting its short term obligations.
AMC's Quick ratio of 1.47 is fine compared to the rest of the industry. AMC outperforms 69.70% of its industry peers.
Industry RankSector Rank
Current Ratio 2.31
Quick Ratio 1.47
AMC.DE Yearly Current Assets VS Current LiabilitesAMC.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

5

3. Growth

3.1 Past

The earnings per share for AMC have decreased strongly by -155.42% in the last year.
AMC shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -33.05%.
Measured over the past years, AMC shows a quite strong growth in Revenue. The Revenue has been growing by 8.42% on average per year.
EPS 1Y (TTM)-155.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
Revenue 1Y (TTM)-33.05%
Revenue growth 3Y17.35%
Revenue growth 5Y8.42%
Sales Q2Q%-7.02%

3.2 Future

AMC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 63.36% yearly.
The Revenue is expected to grow by 11.24% on average over the next years. This is quite good.
EPS Next Y31.2%
EPS Next 2Y47.08%
EPS Next 3Y60.09%
EPS Next 5Y63.36%
Revenue Next Year-9.72%
Revenue Next 2Y-1.49%
Revenue Next 3Y3.9%
Revenue Next 5Y11.24%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AMC.DE Yearly Revenue VS EstimatesAMC.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
AMC.DE Yearly EPS VS EstimatesAMC.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 20 30

1

4. Valuation

4.1 Price/Earnings Ratio

AMC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 235.35, the valuation of AMC can be described as expensive.
69.70% of the companies in the same industry are cheaper than AMC, based on the Price/Forward Earnings ratio.
AMC is valuated expensively when we compare the Price/Forward Earnings ratio to 23.09, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 235.35
AMC.DE Price Earnings VS Forward Price EarningsAMC.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150 200

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AMC indicates a slightly more expensive valuation: AMC is more expensive than 72.73% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 29.09
AMC.DE Per share dataAMC.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AMC does not grow enough to justify the current Price/Earnings ratio.
AMC's earnings are expected to grow with 60.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.08%
EPS Next 3Y60.09%

3

5. Dividend

5.1 Amount

AMC has a Yearly Dividend Yield of 1.70%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.14, AMC has a dividend in line with its industry peers.
AMC's Dividend Yield is slightly below the S&P500 average, which is at 2.32.
Industry RankSector Rank
Dividend Yield 1.7%

5.2 History

The dividend of AMC is nicely growing with an annual growth rate of 13.04%!
Dividend Growth(5Y)13.04%
Div Incr Years3
Div Non Decr Years3
AMC.DE Yearly Dividends per shareAMC.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

AMC has negative earnings and hence a negative payout ratio. The dividend may be in danger.
AMC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-32.53%
EPS Next 2Y47.08%
EPS Next 3Y60.09%
AMC.DE Yearly Income VS Free CF VS DividendAMC.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

ALBEMARLE CORP

FRA:AMC (10/22/2025, 7:00:00 PM)

77.61

-1.79 (-2.25%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners99.06%
Inst Owner ChangeN/A
Ins Owners0.37%
Ins Owner ChangeN/A
Market Cap9.13B
Revenue(TTM)4.99B
Net Income(TTM)-1096204000
Analysts68.39
Price Target72.14 (-7.05%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.7%
Yearly Dividend2.27
Dividend Growth(5Y)13.04%
DP-32.53%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)91.46%
Min EPS beat(2)69.72%
Max EPS beat(2)113.21%
EPS beat(4)2
Avg EPS beat(4)-30.22%
Min EPS beat(4)-249.28%
Max EPS beat(4)113.21%
EPS beat(8)3
Avg EPS beat(8)-20.6%
EPS beat(12)7
Avg EPS beat(12)-3.87%
EPS beat(16)11
Avg EPS beat(16)2.43%
Revenue beat(2)1
Avg Revenue beat(2)0.26%
Min Revenue beat(2)-7.88%
Max Revenue beat(2)8.39%
Revenue beat(4)1
Avg Revenue beat(4)-2.61%
Min Revenue beat(4)-8.69%
Max Revenue beat(4)8.39%
Revenue beat(8)4
Avg Revenue beat(8)-0.47%
Revenue beat(12)4
Avg Revenue beat(12)-1.94%
Revenue beat(16)6
Avg Revenue beat(16)-0.69%
PT rev (1m)1.64%
PT rev (3m)3.87%
EPS NQ rev (1m)-0.57%
EPS NQ rev (3m)-92.94%
EPS NY rev (1m)2.55%
EPS NY rev (3m)-3.85%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)0.23%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)1.86%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 235.35
P/S 2.12
P/FCF N/A
P/OCF 13.58
P/B 1.03
P/tB 1.27
EV/EBITDA 29.09
EPS(TTM)-2.34
EYN/A
EPS(NY)0.33
Fwd EY0.42%
FCF(TTM)-1.33
FCFYN/A
OCF(TTM)5.72
OCFY7.36%
SpS36.62
BVpS75.1
TBVpS61.12
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.34%
ROE -10.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.76%
FCFM N/A
ROA(3y)6.03%
ROA(5y)4.56%
ROE(3y)12.4%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.02%
GM growth 5Y-49.18%
F-Score4
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA 7.46
Cap/Depr 146.27%
Cap/Sales 19.25%
Interest Coverage N/A
Cash Conversion 182.86%
Profit Quality N/A
Current Ratio 2.31
Quick Ratio 1.47
Altman-Z 1.76
F-Score4
WACC7.63%
ROIC/WACCN/A
Cap/Depr(3y)401.9%
Cap/Depr(5y)389.55%
Cap/Sales(3y)23.64%
Cap/Sales(5y)25.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-155.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
EPS Next Y31.2%
EPS Next 2Y47.08%
EPS Next 3Y60.09%
EPS Next 5Y63.36%
Revenue 1Y (TTM)-33.05%
Revenue growth 3Y17.35%
Revenue growth 5Y8.42%
Sales Q2Q%-7.02%
Revenue Next Year-9.72%
Revenue Next 2Y-1.49%
Revenue Next 3Y3.9%
Revenue Next 5Y11.24%
EBIT growth 1Y79.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year159.37%
EBIT Next 3Y44.89%
EBIT Next 5Y36.66%
FCF growth 1Y-118.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70.5%
OCF growth 3Y26.81%
OCF growth 5Y-0.49%